Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label, Multicenter, Mechanism Validation Study to Evaluate the Safety, Efficacy and Tolerability of KP-1461 as Monotherapy for 124 Days in Antiretroviral-experienced, HIV-1-infected Subjects

NCT00504452 is registered in ClinicalTrials.gov with Koronis Pharmaceuticals. as lead sponsor.

NCT NCT00504452
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00504452 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label, Multicenter, Mechanism Validation Study to Evaluate the Safety, Efficacy and Tolerability of KP-1461 as Monotherapy for 124 Days in Antiretroviral-experienced, HIV-1-infected Subjects
Lead sponsor
Koronis Pharmaceuticals.
Phase
Phase 2
Overall status
Terminated
Start date
July 31, 2007
Completion date
June 30, 2009
Enrollment
27 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections